ArticleDiabetes care2017

Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease.

Monika A Niewczas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.